540204 — Eiko Lifesciences Balance Sheet

0.000.00%

Last trade - 00:00

Basic MaterialsSpeculativeMicro CapNeutral

Annual balance sheet for Eiko Lifesciences, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	4.46	6.12	133	118	136
Net Total Accounts Receivable
Net Total Receivables	45.6	71.1	131	108	202
Total Inventory
Total Other Current Assets
Total Current Assets	124	93	309	329	474
Net Property, Plant And Equipment	143	139	136	231	221
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	349	310	527	661	894
Accounts Payable
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	60.1	12	15	62.7	154
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	62.6	16.2	20.6	93.1	206
Common Stock
Retained Earnings (Accumulated Deficit)
Total Equity	286	294	507	568	688
Total Liabilities & Shareholders' Equity	349	310	527	661	894
Total Common Shares Outstanding